Other
Arizona Biomedical Research Commission (ABRC)
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
Failure Rate
0.0%
0 terminated/withdrawn out of 5 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
1 recruiting
Enrollment Performance
Analytics
N/A
2(40.0%)
Phase 4
1(20.0%)
Phase 2
1(20.0%)
Phase 1
1(20.0%)
5Total
N/A(2)
Phase 4(1)
Phase 2(1)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT07103720Phase 4Completed
The Nonirritating Concentrations of Midazolam, Ketamine, and Ondansetron
Role: collaborator
NCT07347405Phase 1Recruiting
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Role: collaborator
NCT04840069Phase 2Unknown
Radiotherapy Planning Using Fluciclovine PET in Patients With Newly Diagnosed Glioblastoma
Role: collaborator
NCT03145883Not ApplicableCompleted
Exercise and Asthma in Obese Adults
Role: collaborator
NCT01082016Not ApplicableUnknown
Sleep Promotion in Critically Ill and Injured Patients Cared for in the Intensive Care Unit
Role: collaborator
All 5 trials loaded